Gemma Zucchelli
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 05, 2021
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study.
Journal: Clinical colorectal cancer
Published: February 21, 2021
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Journal: British journal of cancer
Published: January 02, 2021
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 27, 2020
BRAF mutant metastatic colorectal cancers: new arrows in our quiver.
Journal: Annals of translational medicine
Published: February 05, 2020
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation.
Journal: The Journal of molecular diagnostics : JMD
Published: May 17, 2019
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable.
Journal: ESMO open
Published: January 19, 2019
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.
Journal: Clinical colorectal cancer
Published: January 11, 2019
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.
Journal: Scientific reports
Published: October 24, 2018
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib.
Journal: The pharmacogenomics journal
Published: June 05, 2018
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
Journal: British journal of cancer
Published: November 09, 2017
Last Updated: 09/26/2026